
Volcano dormant for 250,000 years could be on verge of devastating eruption, researchers fear
A 'zombie' volcano that has lain dormant for 250,000 years is on the brink of blowing its top, scientists fear.
Experts at Oxford University say Uturuncu, in the Andes Mountains of Bolivia, is showing increased seismic activity and gas emissions.
The unrest suggests a deadly and destructive eruption is imminent, they predict.
This unrest is visible in a distinctive 'sombrero' pattern of ground deformation, where the land at the center of the volcano is rising while the surrounding area is sinking.
The Oxford researchers discovered that this activity is due to the movement of liquid and gas beneath the crater, which sits above the largest known magma body in the Earth's crust.
Uturuncu stands over 19,700ft high and is a stratovolcano - a large, steep, cone-shaped volcano built up by layers of hardened lava, volcanic ash and rock.
Mount St Helens and Mount Vesuvius are also stratovolcanoes known for their catastrophic eruptions.
Uturuncu lies within 25 miles of three towns, and an eruption could cause widespread damage and pose a serious threat to life, researchers warned.
It is about halfway between two major cities in South America - La Paz in Bolivia and Santiago in Chile.
Lava flows would engulf these nearby communities, while volcanic ash could spread across Bolivia, Argentina and Chile.
More than 1,700 earthquakes have been detected around the volcano recently, leading scientists to study Uturuncu and determine how a dead volcano could come back to life.
The research team used seismic tomography, a technique similar to medical scans, to create images of the inside of the volcano.
By studying how seismic waves move through different materials, they were able to build a detailed 3D view of Uturuncu's interior.
They also looked at the volcano's physical makeup, including the types of rocks, to better understand what's happening underground.
Their analysis revealed possible paths where hot fluids are moving upward and where gases and liquids are gathering in chambers beneath the crater.
The scientists believe this buildup is likely causing the ground in the center to rise - but they said the chances of a full eruption are still low.
Co-author Professor Matthew Pritchard from Cornell University said: 'The methods in this paper could be applied to the more than 1,400 potentially active volcanoes and to the dozens of volcanoes like Uturuncu that aren't considered active but that show signs of life - other potential zombie volcanoes.'
California's Long Valley Caldera, a supervolcano, is also deemed a 'zombie' volcano as it last erupted more than 550 years ago.
As is the Yellowstone Caldera that is closely monitored by scientists.
'The most recent volcanic activity at Yellowstone consisted of rhyolitic lava flows that erupted approximately 70,000 years ago,' according to the US Geological Survey (USGS).
'The largest of these flows formed the Pitchstone Plateau in southwestern Yellowstone National Park.'
One of the most famous volcanoes on Earth, Yellowstone is located beneath a national park spanning three states – Idaho, Wyoming and Montana.
While scientist are unsure if the two volcanoes in the U.S. will ever erupt, they are preparing for Mount Spurr to blow.
In March, Alaskan officials warned it could erupt in the next few weeks or months after observing increase seismic activity, ground deformation and gas emission.
Mount Spurr also sits about 78 miles from Anchorage, home to nearly 300,000 people, which would be blanketed in thick volcanic ash.
In a Thursday updated, the Alaska Volcano Observatory (AVO) said 'unrest continues,' as 'frequent small volcanic earthquakes were detected beneath the volcano over the past day.'
The eruption would set off a chain reaction causing i nternational chaos.
A massive cloud of ash billowing 50,000ft into the air would force international hubs such as Ted Stevens Anchorage International Airport (ANC) and potentially Fairbanks International Airport (FAI) to shut down.
Halting all incoming and departing flights at these airports could have a ripple effect across the country, resulting in widespread delays and cancelations and even disrupting the global supply chain.
Hundreds of planes fly over Anchorage and Fairbanks every day, and it's not just passenger flights that would be impacted. ANC is the fourth-busiest cargo airport in the world, with more than 8,000 cargo flights passing through each month.
Then last time Mount Spurr erupted - in 1992 - ANC shut down for 20 hours while the ash cloud hung over Anchorage. It darkened skies in the middle of the day, and ultimately settled an eighth of an inch thick across the city.
When Mount Spurr blows, the resulting ash cloud will pose a significant hazard to airplanes because the particles are highly abrasive.
Flying through an ash cloud can quickly damage windscreens, fuselage surfaces, compressor fan blades and even kill the plane's engine. Ash particles can also cause critical navigational and operational instruments to fail.
All of this means that it is extremely dangerous to fly a plane while a volcanic eruption is occurring nearby. So, all airports in areas affected by the ash cloud will have to shut down.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
4 days ago
- Telegraph
Endangered species could be saved by faeces, say scientists
Animal dung could be used to save endangered species, scientists believe. A new trial by the University of Oxford and Chester Zoo is aiming to harvest living cells from faeces in the hope they could be transformed into stem cells and eventually sperm and eggs. If successful, it could allow conservationists to collect genetic samples of rare and endangered animals from their waste without having to bother, or even see, the creature itself. The cells could be used to inseminate or clone animals and bring them back from the brink of extinction. Dr Rhiannon Bolton, carrying out research on dung from lions, elephants, giraffes and okapi at Chester Zoo, said: 'If this works, it could be a total game-changer. Right now, UK veterinary guidelines mean you can only collect genetic samples in very specific circumstances or following death, which limits the samples you can collect. 'It's early days yet, but this would allow us to collect cells from a far broader range of animals than we currently can, both individuals within a species and in terms of different species. 'It would make collecting and storing living animal cells non-invasive, cost-effective and efficient.' Oxford is currently trialling new techniques to isolate, wash and culture living cells to store them for conservation purposes. The faecal matter is processed to strip away anything left by the animal's diet or bacteria, allowing scientists to separate out living cells from the donor animal, which can then be extracted and cultured. These living cells have the potential to be used to create stem cells further down the line. Stem cells in turn could become sperm and egg cells, which would be used in conservation breeding or even cloning. The International Union for Conservation of Nature estimates that more than 41,000 species are currently under threat of extinction. Dr Bolton said: 'The keepers and scientists at the zoo pick up samples left in animal habitats. Because these are new techniques, we're trying to collect the freshest samples possible, so I'll get a delivery to the zoo lab, which is processed here. 'The clean cells are then posted to Oxford on the same day. We're looking at a range of animals as the cells from some species might be harder to culture than others. It's likely that the techniques will have to be tweaked for different species.' Currently, the samples must be collected quickly to ensure their freshness, so zoo animals are the perfect donors, but this technique could one day be used in the field, preserving cells from rare animals in the wild. The goal is to bank as much material as possible to prevent extinctions.' Chester Zoo already monitors the dung of its animals to track their health and breeding potential. By testing hormones in animal scat, scientists at the zoo can tell whether animals are ready to mate. Dr Sue Walker, the head of science at Chester Zoo, said: 'Faecal testing is integrated into the daily care of our animal species. We use it to monitor the reproductive and overall health of the animals. 'For instance, we track progesterone in the females which allows us to predict their cycles and lets us know when they are likely to be receptive to a breeding partner, and hormonal analysis also gives us a picture of how they respond to their environment. It helps us offer them optimal care. 'As a conservation zoo, many of the animals we look after are critically endangered. This means their genetics are extremely valuable to the survival of a species as a whole. As science advances, these methods could offer a lifeline to species on the brink.'


The Independent
4 days ago
- The Independent
Weight-loss drugs among breakthrough trials offering ‘hope' for dementia prevention
Dozens of breakthrough drug trials, including one using the main ingredient in weight-loss jabs, offer patients 'hope' for the treatment and prevention of dementia and Alzheimer's disease. Some 138 treatments are being assessed in clinical trials in 2025 - an 11 per cent rise on the year before - according to new research published on Tuesday. Experts have said that 2025 could be a 'landmark year' in breakthrough medicines as four drugs that could prevent the disease, not just treat it, have progressed to large clinical trials. Some trials include drugs currently used to treat other conditions. One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drugs Ozempic and Wegovy, can slow the progression of dementia. An estimated 982,000 people are living with dementia in the UK, and this is projected to rise to 1.4 million in 2040, according to the Alzheimer's Society. Dr Emma Mead, chief scientific officer of the Oxford Drug Discovery Institute, added: 'Today we are at a tipping point in dementia research as we understand more and more about the diseases that drive dementia. 'This gives us opportunities to slow and ultimately stop this devastating condition, and today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments.' Dr Richard Oakley, associate director of research at Alzheimer's Society, said: '2025 is shaping up to be a landmark year for Alzheimer's disease drug development. 'With more trials underway than ever before and more drugs entering the pipeline, there is hope on the horizon for the nearly one million people living with dementia in the UK.' A report from the University of Nevada in the US and published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions, said a 'robust' range of drugs was being trialled in 2025 and a 'notable increase' showed 'momentum toward identifying new therapies for the treatment of alzheimer's disease'. Experts said that drugs, such as such as lecanemab and donanemab, that target amyloid protein build-up in the brain - a key characteristic of both diseases - are 'only one part of the overall strategy' as they expressed excitement over the variety of new drugs being tested. James Rowe, professor of cognitive neurology at the University of Cambridge and consultant neurologist, said: 'One of the most exciting things of this report is the number of large-scale late-stage trials on prevention. And the aspiration to prevent, not just treat, is starting to be seen in the figures we see in these charts today.' He added: 'The ones that are in trial at the moment are really… bringing forward an effective treatment to earlier stage.' For instance, people with a genetic risk of Alzheimer's could receive some drugs earlier to see if they protect them against developing the disease. Dr Sheona Scales, director of research at Alzheimer's Research UK, said that, as well as more drugs coming through the pipeline, the treatment targets are 'more diverse' and 'looking at all stages of the disease'. She added: 'What this paper is showing us is that the pipeline of drug development is growing, it's diversifying and accelerating.' Meanwhile, academics said lecanemab and donanemab, which can be used for treating mild cognitive impairment in Alzheimer's patients, are an 'important first step' in the battle against the disease. The treatments were initially approved for UK use by regulators but then deemed not cost-effective for NHS use. The National Institute for Health and Care Excellence (NICE) is taking more evidence on donanemab and lecanemab and is expected to announce its decision in the summer. Dr Scales added: 'Lecanemab and donanemab have represented a huge leap forward in our understanding and ability to be able to treat Alzheimer's disease. 'What they've done is they've proved that we're able to modify the course of Alzheimer's disease, and what that has done is opened up the door to future treatments that we hope are more effective, easier to deliver and and able to deliver for our patients.'


The Independent
30-05-2025
- The Independent
Scientists finally crack mystery of how clapping generates sound
Scientists have finally unravelled the complex process that generates sound during handclaps, a discovery that shows how even simple acts can be rich with physics. The research, published in the journal Physical Review Research, shows that the characteristic ' pop ' sound of a clap is not just from two hands smashing into each other but a much more complex phenomenon. The key to generating sound from clapping is a cavity of air that is compressed and pushed out of a small space. Scientists followed an interdisciplinary approach to understand clapping, using live experiments, theoretical modelling and silicone replicas of human hands. They modified the volume and duration of claps by changing the speed, the shape of the hands and even the skin softness. 'We clap all the time but we haven't thought deeply about it. That's the point of the study,' said study co-author Yicong Fu from Cornell University, 'to explain the world with deeper knowledge and understanding.' 'The point was not to look just at the acoustics, or the flow excitation or the collision dynamics, but to look at them all simultaneously,' Likun Zhang, another study author from the University of Mississippi, said. 'That's an interdisciplinary effort that allows us to really understand how sound relates to hand clapping.' The study shows that when hands come together during a clap, they create a pocket of air between the palms. This pocket is rapidly expelled from the narrow opening between the forefinger and thumb, causing the air molecules to vibrate. Scientists liken this vibration to the Helmholtz resonance principle, which is behind the tone heard when blowing across the mouth of an empty bottle. 'Traditional Helmholtz resonators have rigid walls like the glass walls of a bottle. This produces a long-lasting sound that attenuates very slowly because most of the energy contributes to the acoustic signal,' Dr Zhang explained. 'But when we have elastic walls – let's say our hands – there is going to be more vibration of the solid material, and all of that motion absorbs energy away from the sound.' This is why clapping generates a single short 'pop' as opposed to a longer noise, researchers say. Scientists hope their research can help inform music education, where handclaps are often used for rhythm timing. The study also shows that every person's clap has a different sound and a different frequency, indicating that clapping can be used in the future as an identification method, like how we use fingerprints. 'One of the most promising applications of this research is human identification. Just through the sound, we could tell who made it,' Guoqin Liu, another author of the study, said.